LCTX Equity Ratio
Lineage Cell Therapeutics, Inc. Common Stock · Equity Ratio
LCTX Equity Ratio
Current (TTM)57.35%retrieved
LCTX Equity Ratio (95.83% → 57.35%)
Latest values, visible window
High-resolution chart · PNG
LCTX equity ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 39.5696% | |
| 69.2302% | |
| 62.7793% | |
| 59.3051% | |
| 52.8351% | |
| 89.1152% | |
| 90.023% | |
| 92.3077% | |
| 93.8814% | |
| 82.7147% | |
| 28.408% | |
| 48.6723% | |
| 25.638% | |
| 32.2185% | |
| 62.5053% | |
| 71.6544% | |
| 52.4556% | |
| -419.7967% | |
| -1,739.7797% | |
| -286.7334% | |
| -10.0359% | |
| 22.6585% | |
| -226.8268% | |
| -78.2809% | |
| -5.1043% | |
| 78.5543% | |
| 89.5131% | |
| 85.7143% | |
| 85.0746% | |
| 93.3333% | |
| 88.8889% | |
| 98.3051% | |
| 97.1429% | |
| 95.8333% |